Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Agonists of ROR GAMMAt

Agonists of ROR GAMMAt

US Patent 12012374 · Granted Jun 18, 2024

Estimated economic value: $221,380,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cyclic dinucleotides as anticancer agents2024
Cyclic dinucleotides as anticancer agents2023
Cyclic dinucleotides as anticancer agents2023
Cyclic dinucleotides as anticancer agents2023
Cyclic dinucleotides as anticancer agents2023
Cyclic dinucleotides as anticancer agents2023
Cyclic dinucleotides as anticancer agents2022
Cyclic dinucleotides as anticancer agents2022
Cyclic dinucleotides as anticancer agents2022
Cyclic dinucleotides as anticancer agents2022
Cyclic dinucleotides as anticancer agents2021
Cyclic dinucleotides as anticancer agents2021